Science On Demand
Novel CAR-T Therapies and Bioanalytical Assay Implementation
Access It Now!
Complete the form to view the recording.Share this resource:
Dr. Corinna Fiorotti, Scientific Officer at BioAgilytix, gave a presentation at the 2020 SelectScience Virtual Summit on Cancer and Immunology Research to discuss the bioanalytical assays that are used for CAR-T therapies. It was so well-received that we are making the recording accessible for your viewing as well!
Access the recording to hear her discuss:
- The evolution of cell therapies with a closer look at the different generations of CAR-T cells being developed today.
- Mitigation strategies to address safety concerns regarding CAR-T therapies, which are challenged by the complexity of their production and by the adverse events related to their activity.
- The bioanalytical considerations for CAR-T therapies and why the development & validation of robust, accurate methods is vital to monitor persistance of CAR-T cells and test their safety and efficacy.
- What the future holds for these exciting therapeutic modalities.